Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Aug 2, 2017, during market hours
10-Q filed Aug 2, 2017, 33 days after period end · 0001396814-17-000024
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $70.14M | $69.64M | $59.15M | $47.17M |
| Net Income | -$19.74M | -$7.96M | $8.00K | -$5.04M |
| EPS Diluted | -$0.49 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.21 |
| $0.00 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.